| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $316K | — | -3.1% |
| Cost of Revenue | $201K | — | +59.5% |
| Gross Profit | $115K | — | -42.5% |
| R&D Expense | $3.9M | — | +36.1% |
| SG&A Expense | $2.5M | — | +1.0% |
| Operating Income | -$6.3M | — | -22.2% |
| Pre-tax Income | -$6.1M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.3M | -27.8% | +33.2% |
| Current Assets | $16.9M | -23.4% | -37.4% |
| Total Assets | $33.7M | -13.0% | -5.0% |
| Current Liabilities | $32.2M | -0.5% | +601.7% |
| Stockholders' Equity | -$11.4M | -66.0% | -115.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.4M | — | -33.6% |
| Capital Expenditures | $116K | — | -44.2% |
| Investing Cash Flow | $3.9M | — | +558.1% |
| Free Cash Flow | -$5.5M | — | -29.8% |
| -1.7% |
| Income Tax | -$8K | — | — |
| Net Income | -$5.8M | — | +0.5% |
| EPS (Basic) | -$0.65 | — | +39.8% |
| EPS (Diluted) | -$0.65 | — | +39.8% |